Autolus Therapeutics plc (AUTL)
Nasdaq: AUTL · Biological Products, (No Diagnostic Substances) · London, GB · filing with the SEC since 2018
Who owns Autolus Therapeutics plc
As filed with the SECHolders of 5% or more
4
MAK Capital Fund LP holds 12.6% of Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share, as its SCHEDULE 13G/A filed May 15, 2026 says.
Directors and officers
21
report now, of 21 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
MAK Capital Fund LP
SCHEDULE 13G/A · filed May 15, 2026 · Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share · 11.3% in Feb 13, 2026
Syncona Portfolio Limited
SCHEDULE 13G/A · filed May 7, 2025 · Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share.
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · American Depositary Shares, each representing one ordinary share, par value $0.000042 per share · 5.94% in May 15, 2026
Renata Kellnerova
SCHEDULE 13D/A · filed Aug 28, 2026 · ADSs, each representing one ordinary share, nominal value $0.000042 per share, and ordinary shares, nominal value $0.000042 per share
Fmr LLC
SCHEDULE 13G/A · filed May 12, 2025 · COMMON STOCK · reported falling below 5%
Deep Track Capital, LP
SCHEDULE 13G/A · filed Nov 14, 2025 · American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share · reported falling below 5%
Wellington Management Group LLP
SCHEDULE 13G/A · filed Oct 6, 2025 · Common Stock · reported falling below 5%, from 10.2% in Apr 4, 2025
What AUTL reports owning in othersstakes of 5% or more, and other ties
5 subsidiaries in 4 countries, from the list filed with the 10-K filed Mar 27, 2026.
Insider tradesForm 4
1sales
0purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 21 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Piccina Cintia | U.S. CCO & Country Gen Manager | 1 | $0 | 0 | 0 | $0 |